Delivery Order SPE2DB20D3101-SPE2DB24FQXC9

Award Date 12/18/23
Potential Completion Date 12/19/23
Potential Value $3.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,118.64, is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,747.54 firm fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution in 200 ml vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities to support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a ceiling value of $1,045.92 and a completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,720.12 and is for the supply of Lacosamide 10 mg/ml solution in 200 ml containers. The contract has an ultimate completion date of January 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lacosamide 10 mg/ml solution. The order, valued at $2,209.92, is part of a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,032.18, is a Firm Fixed Price Delivery Order for the supply of Lacosamide 10 mg/ml solution in 200 ml bottles. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lacosamide, a medication used to treat certain types of seizures, with a ceiling value of $1,535.76 and an ultimate completion date of August 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds several Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Lacosamide 10 mg/mL solution in 200 mL bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,406.74 and an ultimate completion date of April 18, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, is fulfilling this contract under a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FQXC9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, which runs through December 2025. The delivery order is for the supply of Lacosamide 10 mg/ml solution in 200 ml containers, a prescription medication used to treat epilepsy. The contract is a firm fixed-price delivery order with a ceiling value of $3,570.57 and a completion date of December 19, 2023. The contract was awarded on December 18, 2023 and did not have a set-aside designation, indicating full and open competition. This award is part of Amerisourcebergen's broader role as a major pharmaceutical distributor supporting the medical supply needs of the Department of Defense and other federal healthcare programs.

Generated 2/27/25, 11:03 AM